Abstract
The secretion of gastric acid is regulated both centrally and peripherally. The finding that H2-receptor antagonists are able to reduce or abolish acid secretion due to vagal, gastrinergic, and histaminergic stimulation shows that histamine plays a pivotal role in stimulation of the parietal cell. In the rat, the fundic histamine is released from the ECL cell, in response to gastrin, acetylcholine, or epinephrine, and histamine release is inhibited by somatostatin or by the H3-receptor ligand, R-α-methyl histamine. The parietal cell has a muscarinic, M3, receptor responsible for [Ca]i regulation. Blockade of muscarinic receptors by atropine can be as effective as H2-receptor blockade in controlling acid secretion. However, general effects on muscarinic receptors elsewhere produce significant side effects. The different receptor pathways converge to stimulate the gastric H+, K+-ATPase, the pump responsible for acid secretion by the stomach. This enzyme is an α,β heterodimer, present in cytoplasmic membrane vesicles of the resting cell and in the canaliculus of the stimulated cell. It has been shown that acid secretion by the pump depends on provision of K+Cl− efflux pathway becoming associated with the pump. As secretion occurs only in the canaliculus, this K+Cl− pathway is activated only when the pump inserts into the canalicular membrane. Transport by the enzyme involves reciprocal conformational changes in the cytoplasmic and extracytoplasmic domain. These result in changes in sidedness and affinity for H3O+ and K+, enabling active H+ for K+ exchange. The acid pump inhibitors of the substituted benzimidazole class, such as omeprazole, are concentrated in the canaliculus of the secreting parietal cell and are activated there to form sulfenamides. The omeprazole sulfenamide, for example, reacts covalently with two cysteines in the extracytoplasmic loops between the fifth and sixth transmembrane and the seventh and eighth transmembrane segments of the α subunit of the H+,K+-ATPase, forming disulfide derivatives. This inhibits ATP hydrolysis and H+ transport, resulting in effective, long-lasting regulation of acid secretion. Therefore, this class of acid pump inhibitor is significantly more effective and faster acting than the H2 receptor antagonists. K+ competitive antagonists bind to the M1 and M2 transmembrane segments of the α subunit of the acid pump and also abolish ATPase activity. These drugs should also be able to reduce acid secretion more effectively than receptor antagonists and provide shorter acting but complete inhibition of acid secretion.
Similar content being viewed by others
References
Duke WW, Sachs G, Hirschowitz BI: Vagal stimulation of gastric acid secretion in man by 2 deoxy glucose. Lancet 2:871–876, 1965
Tache Y, Yang H: Brain regulation of gastric acid secretion by peptides. Ann NY Acad Sci 597:128–145, 1990
Håkanson R, Boettcher G, Ekblad F, Panula P, Simonsson M, Dohlsten M, Hallberg T, Sundler F: Histamine in endocrine cells in the stomach. Histochemistry 86:5–17, 1986
Bergqvist EM, Waller M, Hammer L, Öbrink KJ: Histamine as a secretory mediator in isolated gastric glands. In Hydrogen Ion Transport in Epithelia. I Shulz, G Sachs, JG Forte, KJ Ulrich (eds). Amsterdam Elsevier, 1980, pp 429–437
Kopin AS, Lee YM, McBride EW, Miller LJ, Lu M, Lin HY, Kolakowski LF, Beinborn M: Expression cloning and characterisation of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 89:3605–3609, 1992
Dimaline R, Sandvik AK: Histidine decarboxylase gene expression in rat fundus is regulated by gastrin. FEBS Lett 281:20–22, 1991
Lloyd KC, Raybould HE, Tache Y, Walsh JH: Role of gastrin, histamine and acetylcholine in the gastric phase of acid secretion in anesthetized rats. Am J Physiol 262:G747-G755, 1992
Prinz C, Kajimura M, Scott D, Mercier F, Helander HF, Sachs G: Histamine secretion from enterochromaffin like cells. Gastroenterology 105:449–461, 1993
Loo DD, Prinz C, Sachs G: Electrical properties of isolated rat enterochromaffin like cells. FASEB J 7:A24, 1993
Berglindh T: The mammalian parietal cellin vitro. Anw Rev Physiol 46:377–392, 1984
Berglindh T, Sachs G: Histamine uptake and release from isolated gastric glands. In Hormone receptors in Digestion and Nutrition. (G Rosselin, P Fromageot, S Bonfils (eds). Amsterdam, Elsevier, 1979, pp 373–381
Haglund U, Elander B, Fellenius E, Leth R, Rehnberg O, Olbe L: The effects of secretagogues of isolated human gastric glands. Scand J Gastroenterol 17:455–460, 1982
Andersson K, Mattson H, Larsson H: The role of gastric mucosal histamine in acid secretion and experimentally induced lesions in rats. Digestion 46:1–9, 1990
Soll AH: Secretagogue stimulation of [14C]aminopyrine accumulation by isolated canine parietal cells. Am J Physiol 238:G366-G375, 1980
Berglindh T, Helander HF, Öbrink KJ: Effects of secretagogues on oxygen consumption, aminopyrine accumulation and morphology in isolated gastric glands. Acta Physiol Scand 97:401–414, 1976
Pitcher J, Lohse MJ, Codina J, Caron MG, Lefkowitz RJ: Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic receptor kinase, cAMP-dependent protein kinase, and proteinkinase C occurs via distinct molecular mechanisms. Biochemistry 31:3193–3197, 1992
Major JS, Scholes P: The localisation of histamine H2 receptor adenylate cyclase system in canine parietal cells and its inhibition by prostaglandins. Agents Actions 8:324–331, 1978
Berglindh T, Hansen D: Characterization of isolated gastric glands from dog. Fed Proc 43:996A, 1984
Walsh JH, Richardson CT, Fordtran JS: pH dependence of acid secretion and gastrin release in normal and ulcer patients. J Clin Invest 55:462–468, 1975
Johnson LR: The trophic action of gastrointestinal hormones. Gastroenterology 70:278–288, 1976
Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons ME: Definition and antagonism of histamine H2 receptors. Nature 236:385–390, 1972
Wilkes JM, Kajimura M, Scott DR, Hersey SJ, Sachs G: Muscarinic responses of parietal cells. J Membr Biol 122:97–110, 1991
Fukuda K, Kubo T, Akiba I, Maeda A, Mishina M, Numa S: Molecular distinction between muscarinic acetylcholine receptor subtypes. Nature 327:623–625, 1987
Peralta EG, Ashkenazi A, Winslow JW, Ramachandran J, Capon DJ: Differential regulation of PI hydrolysis and adenylate cyclase by muscarinic receptor subtypes. Nature 334:437–439, 1988
Kajimura M, Reuben MA, Sachs G: The muscarinic receptor geen expressed in rabbit parietal cells is the m3 subtype. Gastroenterology 103:870–875, 1992
Pfeiffer A, Rochlitz A, Noelke B, Tacke R, Moser U, Mutschler E, Lambrecht G: Muscarinic receptors mediating acid secretion in isolated rat gastric parietal cells are of the M3 subtype. Gastroenterology 98:218–222, 1990
Hirschowitz BI, Sachs G: Atropine inhibition of insulin, histamine and pentagastrin stimulated gastric electrolyte and pepsin secretion in the dog. Gastroenterology 56:693–702, 1969
Buckley NJ, Bonner TI, Buckley CM, Brann MR: Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35:469–476, 1989
Donahue PE, Bombeck T, Condon RE, Nyhus LM: Proximal gastric vagotomy versus selective vagotomy with antrectomy: Results of a prospective, randomised clinical trial after 4 to 12 years. Surgery 96:585–591, 1984
Michelangeli F, Ruiz MC, Fernandez E, Ciarrocchi A: Role of Ca2+ in H+ transport by rabbit gastric glands studied with A23187 and BAPTA, an incorporated Ca2+ chelator. Biochim Biophys Acta 983:82–90, 1989
Gantz I, Schaeffer M, Delvalle J, Logsdon C, Campbell V, Yamada T: Molecular cloning of a gene encoding the histamine H2 receptor. Proc Natl Acad Sci USA 488:429–433, 1991
Rangachari PK: Histamine: Mercurial messenger in the gut. Am J Physiol 262:G1-G13, 1992
Bado A, Hervatin F, Lewin MJM: Pharmacological evidence for histamine H3 receptor in control of gastric acid secretion in cats. Am J Physiol 260:G631-G635, 1991
Bado A, Moizo L, Laigneau JP, Lewin MJM: Pharmacological characterization of histamine H3 receptors in isolated rabbit gastric glands. Am J Physiol 262:G556-G561, 1992
Chew CS, Hersey SJ, Sahcs G, Berglindh T: Histamine responsiveness of isolated gastric glands. Am J Physiol 238:G312-G320, 1980
Hill SJ: Multiple histamine receptors: Properties and functional characteristics. Biochem Soc Trans 20:122–125, 1992
Chew C: Cholecystokinin, carbacho, gastrin, histamine and forskolin increase [Ca2+]i in gastric glands. Am J Physiol 250:G814-G823, 1986
Negulescu P, Machen TE: Intracellular Ca2+ regulation during secretagogue stimulation of the parietal cell. Am J Physiol 254:C130-C140, 1988
Jackson RJ, Sachs G: Identification of gastric cyclic AMP binding proteins. Biochim Biophys Acta 717:453–458, 1982
Malinowska D, Sachs G, Cuppoletti JG: Gastric H secretion: Histamine activation of protein phosphorylation. Biochim Biophys Acta 972:95–109, 1988
Bianchi Porro G, Parente F: Duodenal ulcer resistant to H2 blockers: An emerging therapeutic problem. Scand J Gastroenterol 23(suppl 153):159–165, 1988
Nwoloko CU, Smith JTL, Gavey C, Sawyerr A, Pounder RE: Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment Pharmacol Ther 4(suppl 1):29–46, 1990
Cabero JL, Li ZQ, Mardh S: Gastrin potentiates histamine stimulated aminopyrine accumulation in isolated rat parietal cells. Am J Physiol 261:G621-G627, 1991
Schepp W, Heim H-K, Ruoff H-J: Comparison of the effect of PGE2 and somatostatin on histamine stimulated14C aminopyrine uptake and cAMP formation in isolated gastric mucosal cells. Agents Actions 13:200–206, 1983
Chen MC, Amirian M, Toomey M, Sanders M, Soll AH: Prostanoid inhibition of canine parietal cells: mediation by inhibiting GTP-binding protein of adenylate cyclase. Gastroenterology 94:1121–1129, 1988
Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandin in rats-prevention of gastric necrosis induced by alcohol, HCI, NaOH, hypertonic HCI and thermal injury. Gastroenterology 77:433–443, 1979
Rainsford KD, Whitehouse MW: Biochemical gastroprotection from acute ulceration induced by aspirin and related drugs. Biochem Pharmacol 29:1281–1289, 1980
Johnson LR, Guthrie PD: Stimulation of rat oxyntic gland mucosal growth by epidermal growth factor. Am J Physiol 238:G131-G134, 1980
Brand SJ, Merchant J, Baackwich D: Stimulation of gastrin gene transcription of epidermal growth factor/TGF and inhibition by somatostatin feed-forward and feedback controls on gastrin synthesis to prevent mucosal ulceration by gastric acid secretion. In: The Stomach as an Endocrine Organ. Amsterdam, Håkanson R, Sundler F (eds). Elsevier, 1991, pp 233–249
Helander HF, Hirschowitz BI: Quantitative ultrastructural studies on gastric parietal cells. Gastroenterology 63:951–961, 1973
Black JA, Forte TM, Forte JG: Inhibition of HCl secretion and the effects on ultrastructure and electrical resistance in isolated piglet mucosa. Gastroenterology 81:509–519, 1981
Smolka A, Helander HF, Sachs G: Monoclonal antibodies against gastric H+,K+-ATPase, Am J Physiol G589–G596, 1983
Dibona DR, Ito S, Berglindh T, Sachs G: Cellular site of acid secretion. Proc Natl Acad Sci USA 76:6689–6693, 1979
Sachs G, Chang HH, Rabon E, Schackman R, Lewin M, Saccomani G: A non-electrogenic H pump in plasma membranes of hog stomach. J Biol Chem 251:7690–7698, 1976
Wolosin JM, Forte JG: Kinetic properties of the KCI transport at the secreting apical membrane of the oxyntic cell. J Membr Biol 71:195–207, 1983
Lindberg UP, Nordberg UP, Alminger T, Brändström A, Wallmark B: The mechanism of action of the gastric acid secretion inhibitor, omeprazole. J Med Chem 29:1327–1329, 1986
Scott D, Helander HF, Hersey SJ, Sachs G: The site of acid secretion in the mammalian parietal cell. Biochim Biophys Acta 1146:73–80, 1993
Moody FG: Oxygen consumption during thiocyanate inhibition of gastric acid secretion in dogs. Am J Physiol 215:127–131, 1968
Fryklund J, Gedda K, Scott D, Sachs G, Wallmark B: Coupling of H+, K+-ATPase activity and glucose oxidation in gastric glands. Am J Physiol 261:G719-G727, 1990
Shull GE, Lingrel JB: Molecular cloning of the gastric H+,K+-ATPase. J Biol Chem 261:16788–16791, 1986
Maeda M, Ishizaki J, Futai M: cDNA cloning and sequence determination of pig gastric (H++K+)-ATPase. Biochem Biophys Res Commun 157:203–209, 1988
Bamberg K, Mercier F, Reuben MA, Kobayashi Y, Munson KB, Sachs G: DNA cloning and membrane topology of the rabbit gastric ATPase alpa subunit. Biochim Biophys Acta 1131:69–77, 1992
Maeda M, Oshiman K-I, Tamura S, Futai M: Human gastric H+,K+-ATPase gene. J Biol Chem 265:9027–9032, 1989
Reuben MA, Lasater L, Sachs G: Characterization of a beta subunit of the gastric H+,K+-ATPase. Proc Natl Acad Sci USA 87:6767–6771, 1990
Shull GE: cDNA cloning of the β subunit of the rat gastric H+,K+-ATPase. J Biol Chem 265:1213–1216, 1990
Baldwin GS: The beta-subunit of the gastric H+/K+-ATPase can occur without the alpha-subunit. FEBS Lett 272:159–162, 1990
Canfield VA, Okamato CT, Chow D, Dorfman J, Gros P, Forte JG, Levenson R: Identification and characterization of a gene for the H+, K+-ATPase beta-subunit. Soc Gen Physiol Ser 46:89–98, 1991
Horisberger JD, Jaunin P, Reuben MA, Lasater LS, Chow DC, Forte JG, Sachs G, Rossier BC, Geering K: The H+,K+-ATPase β subunit can act as a surrogate for the β subunit of Na,K pumps. J Biol Chem 266:19131–19134, 1991
Chow DC, Browning CM, Forte JG: Gastric H+,K+-ATPase activity is inhibited by reduction of disulfidebonds in betasubunit. Am J Physiol 263:C39-C46, 1992
Wallmark B, Stewart HB, Rabon E, Saccomani G, Sachs G: The catalytic cycle of the gastric H+,K+-ATPase. J Biol Chem 255:5313–5319, 1980
Stewart HB, Wallmark B, Sachs G: The interactions of H and K with the partial reactions of the H+,K+-ATPase. J Biol Chem 259:11861–11867, 1981
Polvani C, Sachs G, Blostein R: Sodium ions as substitutes for protons in the gastric H+,K+-ATPase. J Biol Chem 264:17854–17859, 1989
Bamberg K, Sachs G: Membrane Topology of the gastric H+,K+-ATPase α subunit. J Cell Biochem Abst Suppl 17c:21, 1993
Lorentzon P, Jackson RJ, Wallmark B, Sachs G: Inhibition of H+,K+-ATPase by omeprazole in isolated gastric vesicles requires proton transport. Biochim Biophys Acta 897:41–51, 1987
Glynn IM, Karlish SJD: Occluded cations in active transport. Annu Rev Biochem 59:171–205, 1990
Hanzel D, Reggio H, Bretscher A, Forte JG, Mangeat P: The secretion stimulated 80K phosphoprotein of parietal cells is ezrin and has properties of a membrane cytoskeletal linker in the induced apical microvilli. EMBO J 10:2362–2373, 1991
Besancon ML, Shin JM, Mercier F, Munson KB, Miller M, Hersey SJ, Sachs G: Membrane topology and omeprazole labelling of the gastric H+,K+-ATPase. Biochemistry 32:2345–2355, 1993
Mercier F, Bayle D, Besancon M, Joys T, Soumarmon A, Lewin M, Sachs G: Antibody epitope map** of the gastric H+,K+-ATPase. Biochim Biophys Acta 1149:151–165, 1993
Scott D, Munson K, Modyanov N, Sachs G: Determination of the sidedness of the C-terminal region of the gastric H+,K+-ATPase α subunit. Biochim Biophys Acta 1112:246–250, 1993
Munson KB, Balaji VN, Ramnarayan K, Sachs G: Extracytoplasmic region of H+,K+-ATPase labeled by a K+ competitive photoaffinity inhibitor. J Biol Chem 266:18976–18988, 1991
MacLennan DH, Brandl CJ, Korczak B, Green NM: Amino acid sequence of a Ca+Mg-dependent ATPase from rabbit muscle deduced from its complementary DNA sequence. Nature 316:696–700, 1985
Jackson RJ, Mendlein J, Sachs G: Interaction of fluorescein isothiocyanate with the H+,K+-ATPase. Biochim Biophys Acta 731:9–15, 1983
Rabon EC, Bassilian S, Sachs G, Karlish SJD: Conformational transitions of the H+,K+-ATPase studied with sodium ions as a surrogate for protons. J Biol Chem 265:19594–19599, 1990
Rabon E, Sachs G, Bassilian S, Leach C, Keeling D: A K competitive fluorescent inhibitor of the H+,K+-ATPase. J Biol Chem 266:12395–12401, 1991
MacLennan DH, Toyofuku T: Structure-function relationships in the Ca2+ pump of the sarcoplasmic reticulum. Biochem Soc Trans 20:559–562, 1992
Sachs G, Shin JM, Besancon M, Prinz C: The continuing development of acid pump inhibitors. Aliment Pharmacol Ther Suppl 7:4–12, 1993
Shin JM, Besancon ML, Simon A, Sachs G: The site of action of pantoprazole in the gastric H+,K+-ATPase. Biochim Biophys Acta 1148:223–233, 1993
Wallmark B, Briving C, Fryklund J, Munson KB, Jackson R, Mendlein J, Rabon E, Sachs G: Inhibition of gastric H+,K+-ATPase and acid secretion by SCH28080, a substituted pyridyl (1,2α) imidazole. J Biol Chem 262:2077–2084, 1987
Keeling DJ, Malcolm RC, Kaing SM, Leach CA, Ife RJ: AKF 96067 is a reversible luminally acting inhibitor of the gastric H+,K+-ATPase. Biochem Pharmacol 42:123–130, 1991
Lingrel JB, Orlowski J, Shull MM, Price EM: Molecular genetics of the Na+,K+-ATPase. Prog Nucleic Acid Res Mol Biol 38:37–89, 1990
Kaminski JJ, Bristol JA, Puchalski C, Lovey RG, Elliott AJ, Guzik H, Solomon DM, Conn DJ, Domalski MS, Wong SC, Gold EH, Long JF, Chiu PJS, Steinberg M, McPhail AT: Antiulcer agents. 1. Gastric antisecretory and cytoprotective properties of substituted imidazo[1,2-α] pyridines. J Med Chem 28:876–892, 1985
Walan A, Bader JP, Classen M, Lamers CBHW, Piper DW, Rutgersson K, Eriksson S: Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 320:69–75, 1989
Im WB, Blakeman DP, Sachs G: Reversal of antisecretory activity of omeprazole by sulfhydryl compounds in isolated rabbit gastric glands. Biochim Biophys Acta 845:54–59, 1985
Im WB, Blakeman DP, Davis JP: Irreversible inactivation of rat gastric H+,K+-ATPasein vivo by omeprazole. Biochem Biophys Res Commun 126:78–82, 1985
Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L: Effect of omeprazole—a gastric proton pump inhibitor—on pentagastrin stimulated acid secretion in man. Gut 24:270–276, 1983
Takeguchi M, Asano S, Tabuchi Y, Takkeguci N: The presence of H+,K+-ATPase in the crypt of rabbit distal colon demonstrated with monoclonal antibodies against the H+,K+-ATPase. Gastroenterology 99:1339–1346, 1990
Garg LC: Respective roles of H+-ATPase and H+,K+-ATPase in ion transport in the kidney. J Am Soc Nephrol 2:949–960, 1991
Kaunitz JD, Sachs G: Identification of a vanadate sensitive potassium dependent proton pump from rabbit colon. J Biol Chem 216:14005–14010, 1986
Crowson MS, Shull GE: Isolation and characterization of a cDNA encoding the putative distal colon H+,K+-ATPase. Similarity of deduced amino acid sequence to gastric H+,K+-ATPase and Na+,K+-ATPase and mRNA expression in distal colon, kidney and uterus. J Biol Chem 267:13740–13748, 1992
Reuben MA, Starr FL, Birmingham S, Sachs G, Kraut JA: Characterisation of a renal H+,K+-ATPase alpha subunit mRNA found to be identical with gastric H+,K+-ATPase mRNA. Am J Physiol (in press)
Maeda M, Oshiman K, Tamura S, Kaya S, Mahmood S, Reuben MA, Lasater LS, Sachs G, Futai M: The rat H+,K+-ATPase beta subunit gene and recognition of its control region by gastric DNA binding protein. J Biol Chem 266:21584–21588, 1991
Campbell V, Yamada T: Acid secretagogue induced stimulation of gastric parietal cell gene expression. J Biol Chem 264:11381–11386, 1991
Tari A, Wu V, Sachs G, Walsh JH: Regulation of rat gastric H+,K+ ATPase α subunit mRNA by omeprazole. Biochim Biophys Acta 1129:49–56, 1991
Tari A, Yamamoto G, Sumii K, Sumii M, Takehara Y, Haruma K, Kajiyama G, Wu V, Sachs G, Walsh JH: The role of the histamine-2 receptor in the expression of the rat H,K-ATPase α subunit. Am J Physiol 265:G752-G758, 1993
Londong W, Barth H, Dammann HG, Hengels KJ, Kleinert R, Muller P, Rohde H, Simon B: Dose-related healing of duodenal ulcer with the proton pump inhibitor, lansoprazole. Aliment Pharmacol Ther 5:245–254, 1991
Ene MD, Khan-Daneshmend T, Roberts CJC: A study of the effects of SCH 28080 on gastric acid secretion in man. Br J Pharmacol 76:389–391, 1982
Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication ofH. pylori. Lancet 335:1233–1235, 1990
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK:Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131, 1991
Graham DY: Treatment of peptic ulcers caused byHelicobacter pylori. N Engl J Med 328:349–350, 1993
Börsch GMA, Graham DY:Helicobacter pylori. In Pharmacology of Peptic Ulcer Disease. Handbook of Experimental Pharmacology. Berlin, Springer-Verlag, 1991, pp 107–147
Bayerdörffer E, Mannes GA, Sommer A, Höchter W, Weingart J, Hatz R, Lehn N, Ruckdeschel G, Dirshedl P, Stolte M: High dose omeprazole treatment combined with amoxicillin eradicatesHelicobacter pylori. Eur J Gastroenterol Hepatol 4:697–702, 1992
Hunt RH: Treatment of peptic ulcer disease with sucralfate: A review. Am J Med 91:102S-106S, 1991
Oshiman K, Motojima K, Mahmood S, Shimada A, Tamura S, Maeda M, Futai M: Control region and gastric specific transcription of the rat H+,K+-ATPase alpha subunit gene. FEBS Lett 281:250–254, 1991
Bamberg K, Sachs G: Topological Analysis of the gastric H+,K+-ATPase usingin vitro translation. J Biol Chem 1994 (in press)
Gedda K, Scott D, Besancon M, Sachs G: The half-life of the gastric H+,K+-ATPase in the rat. Gastroenterology 269: 16909–16919, 1994
Jewell-Motz EA, Lingrel JB: Site direct mutagenesis of the Na+,K+ ATPase: Consequence of substitutions of negatively charged amino acids localised in the transmembrane domain. Biochemistry 32:13523–13530, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hirschowitz, B.I., Keeling, D., Lewin, M. et al. Pharmacological aspects of acid secretion. Digest Dis Sci 40 (Suppl 2), 3S–23S (1995). https://doi.org/10.1007/BF02214869
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02214869